-
This Pathology Lab Stock Rises 38% in 1 Year: Bonus Shares, a Debt-Free Parent and a Shrinking Promoter Stake
- September 17, 2026
- Posted by: Harsh Piplani
- Category: Best Stocks
No Comments
One diagnostics company delivered a 38% price gain over twelve months while its promoter sold down roughly 20% of the company in two blocks. Here is what actually drove the move.
-
This Diagnostic Chain Stock Rises 43% in 1 Year: What Is Powering the Re-Rating?
- September 17, 2026
- Posted by: Harsh Piplani
- Category: Best Stocks
One southern pathology and radiology network gained 43% in a year on five straight quarters of margin expansion. Here is what drove the move and where the risks sit.
